Pillstats
Rx only · Tablet · Oral

Levonorgestrel And Ethinyl Estradiol

Brands: Amethyst · Dolishale · Ethinyl Estradiol + Levonorgestrel

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4124
US makers3 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.367$0.734$1.10$1.47Dec 2025Apr 2026Jul 2026
$1.157
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
3
Active US suppliers
80%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.1K2.2K3.3K4.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.1K
Rx · 2026 Q1
164K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Ingenus Pharmaceuticals, LLCunknown3SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown1SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.